Blog

Blog2020-04-20T16:59:14+05:30
2505, 2020

Markets Brush off US-China Tensions and Surge on Covid-19 Vaccine News

By |May 25th, 2020|Categories: Finance|0 Comments

Last week started on a positive note with Moderna being among the latest companies to announce encouraging interim Phase 1 data for a covid-19 vaccine candidate. The company, which is partnering with the National Institutes of Health, said that its

1805, 2020

Powell’s Remarks Dampen Reopening Optimism

By |May 18th, 2020|Categories: Finance|0 Comments

Last week started with excitement around the reopening of most economies around the world, businesses beginning to open their shutters and people getting ready to move out of their homes. But the euphoria didn’t last long. The bears began their

1305, 2020

How Brand Messaging Has Adapted to the Coronavirus Crisis

By |May 13th, 2020|Categories: Content Marketing, Marketing|0 Comments

No, I’m not going to start this article with the latest on the number of people infected worldwide with COVID-19 or what the death toll stands at. Everywhere I turn these days, that’s all I get to see. But, what

1105, 2020

Markets Shrugged Off Record Surge in US Unemployment Rate

By |May 11th, 2020|Categories: Finance|0 Comments

The US Labor Department Friday reported a staggering 20.5 million job losses in the country in April, sending the unemployment skyrocketing to 14.7% amid shelter-in-place orders and factory closures to combat the COVID-19 pandemic. While the job losses and unemployment

605, 2020

What Took Oil Prices from $67 to Below Zero in Just Three Months?

By |May 6th, 2020|Categories: Finance|0 Comments

Wild market swings have become the new normal amid the coronavirus outbreak. The steep decline in oil prices came as no surprise. But no one could have imagined even a few weeks back that oil prices would plummet to negative

405, 2020

Market Recovers on Gilead’s COVID-19 Drug

By |May 4th, 2020|Categories: Finance|0 Comments

Gilead Sciences, Inc. grabbed investor attention last week after the company announced positive results of its antiviral drug remdesivir in closely watched clinical trial. Investors cheered the news of a possible treatment for the deadly coronavirus infection, sending the stock

Load More Posts